Chloroquine: Revision history

12 November 2024

• curprev 10:5710:57, 12 November 2024‎ 69.163.248.232 talk‎ 4,397 bytes −30‎ No edit summary undo Tag: Manual revert
• curprev 10:2110:21, 12 November 2024‎ 69.163.248.232 talk‎ 4,427 bytes +10‎ Updated category= to treatment_category= in TreatmentInfo template undo
• curprev 10:1610:16, 12 November 2024‎ 69.163.248.232 talk‎ 4,417 bytes +10‎ Updated category= to treatment_category= in TreatmentInfo template undo
• curprev 10:1510:15, 12 November 2024‎ 69.163.248.232 talk‎ 4,407 bytes +10‎ Updated category= to treatment_category= in TreatmentInfo template undo
• curprev 10:1310:13, 12 November 2024‎ 69.163.248.232 talk‎ 4,397 bytes +10‎ Updated category= to treatment_category= in TreatmentInfo template undo

27 March 2024

• curprev 15:5015:50, 27 March 2024‎ Lazy talk contribs‎ 4,387 bytes +79‎ No edit summary undo
• curprev 08:4608:46, 27 March 2024‎ Lazy talk contribs‎ 4,308 bytes +400‎ No edit summary undo
• curprev 08:4508:45, 27 March 2024‎ Lazy talk contribs‎ 3,908 bytes −23‎ No edit summary undo
• curprev 08:3108:31, 27 March 2024‎ Lazy talk contribs‎ 3,931 bytes +18‎ No edit summary undo

26 March 2024

• curprev 00:5500:55, 26 March 2024‎ Lazy talk contribs‎ 3,913 bytes +2,165‎ No edit summary undo

19 March 2024

• curprev 08:2308:23, 19 March 2024‎ Lazy talk contribs‎ 1,748 bytes +1,748‎ Created page with "{{TreatmentInfo |drug_name=Chloroquine and Hydroxychloroquine |FDA_approval=No (for glioblastoma treatment) |used_for=Glioblastoma, in combination with traditional chemotherapy agents |clinical_trial_phase=Reviewed in recent meta-analyses and studies |common_side_effects=Generally well-tolerated; specific studies noted minimal impact on adverse event incidence |OS_without=BCNU alone: median survival of 11 months |OS_with=Chloroquine with BCNU: median survival significant..."